# Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease

> **NCT02233907** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 595 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Ventilat® - metered dose inhaler

## Key facts

- **NCT ID:** NCT02233907
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2001-08
- **Final completion:** —
- **Target enrollment:** 595 (ACTUAL)
- **Last updated:** 2014-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02233907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02233907, "Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02233907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*